{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:24Z","timestamp":1792783404324,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nanjing Municipal Health Bureau Medical Science and Technology Development Foundation","award":["ZKX23020"],"award-info":[{"award-number":["ZKX23020"]}]},{"name":"Jiangsu Pharmaceutical Association Research Foundation of Pharmacy","award":["202495070"],"award-info":[{"award-number":["202495070"]}],"id":[{"id":"https:\/\/ror.org\/01c3kcb55","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12012-026-10174-z","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T12:25:20Z","timestamp":1788697520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["QT Prolongation, Ventricular Arrhythmia, and Cardiac Arrest Signals During Ceftriaxone Co-therapy with Individual Proton Pump Inhibitors: A Multidatabase Study"],"prefix":"10.1007","volume":"26","author":[{"given":"Yechao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingnuo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haobin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,6]]},"reference":[{"key":"10174_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2165\/00003495-198427060-00001","volume":"27","author":"DM Richards","year":"1984","unstructured":"Richards, D. M., Heel, R. C., Brogden, R. N., Speight, T. M., & Avery, G. S. (1984). Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs, 27, 469\u2013527.","journal-title":"Drugs"},{"key":"10174_CR2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","volume":"65","author":"MA Jackson","year":"2016","unstructured":"Jackson, M. A., Goodrich, J. K., Maxan, M-E., et al. (2016). Proton pump inhibitors alter the composition of the gut microbiota. Gut, 65, 749\u2013756.","journal-title":"Gut"},{"key":"10174_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.5009\/gnl20036","volume":"15","author":"GH Kim","year":"2021","unstructured":"Kim, G. H. (2021). Proton pump inhibitor-related gastric mucosal changes. Gut And Liver, 15, 646\u2013652.","journal-title":"Gut And Liver"},{"key":"10174_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/1751-2980.12155","volume":"15","author":"M Turnock","year":"2014","unstructured":"Turnock, M., Pagnoux, C., & Shore, K. (2014). Severe hypomagnesemia and electrolyte disturbances induced by proton pump inhibitors. Journal of Digestive Diseases, 15, 459\u2013462.","journal-title":"J Dig Dis"},{"key":"10174_CR5","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.7150\/ijms.34141","volume":"16","author":"C Teng","year":"2019","unstructured":"Teng, C., Walter, E. A., Gaspar, D. K. S., Obodozie-Ofoegbu, O. O., & Frei, C. R. (2019). Torsades de pointes and QT prolongation associations with antibiotics: A pharmacovigilance study of the FDA adverse event reporting system. International Journal Of Medical Sciences, 16, 1018\u20131022.","journal-title":"International Journal Of Medical Sciences"},{"key":"10174_CR6","doi-asserted-by":"publisher","first-page":"e2339893","DOI":"10.1001\/jamanetworkopen.2023.39893","volume":"6","author":"AD Bai","year":"2023","unstructured":"Bai, A. D., Wilkinson, A., Almufleh, A., et al. (2023). Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole. JAMA Netw Open, 6, e2339893.","journal-title":"JAMA Netw Open"},{"key":"10174_CR7","doi-asserted-by":"publisher","first-page":"106202","DOI":"10.1016\/j.jinf.2024.106202","volume":"89","author":"S Mitsuboshi","year":"2024","unstructured":"Mitsuboshi, S., Imai, S., Kizaki, H., & Hori, S. (2024). Concomitant use of lansoprazole and ceftriaxone is associated with an increased risk of ventricular arrhythmias and cardiac arrest in a large Japanese hospital database. Journal of Infection, 89, 106202.","journal-title":"Journal of Infection"},{"key":"10174_CR8","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","volume":"13","author":"S Cuschieri","year":"2019","unstructured":"Cuschieri, S. (2019). The STROBE guidelines. Saudi Journal of Anaesthesia, 13, S31\u2013S34.","journal-title":"Saudi J Anaesth"},{"key":"10174_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s40264-024-01423-7","volume":"47","author":"M Fusaroli","year":"2024","unstructured":"Fusaroli, M., Salvo, F., Begaud, B., et al. (2024). The REporting of a disproportionality analysis for DrUg safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): Explanation and elaboration. Drug Safety, 47, 585\u2013599.","journal-title":"Drug Safety"},{"key":"10174_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson, A. E. W., Bulgarelli, L., Shen, L., et al. (2023). MIMIC-IV, a freely accessible electronic health record dataset. Scientific Data, 10, 1.","journal-title":"Sci Data"},{"key":"10174_CR11","doi-asserted-by":"publisher","first-page":"1413944","DOI":"10.3389\/fphar.2024.1413944","volume":"15","author":"Y Qiao","year":"2024","unstructured":"Qiao, Y., Chen, Y., Wang, Q., et al. (2024). Safety profiles of doxycycline, minocycline, and tigecycline in pediatric patients: a real-world pharmacovigilance analysis based on the FAERS database. Frontiers In Pharmacology, 15, 1413944.","journal-title":"Frontiers In Pharmacology"},{"key":"10174_CR12","doi-asserted-by":"publisher","first-page":"1466875","DOI":"10.3389\/fphar.2024.1466875","volume":"15","author":"X Dai","year":"2024","unstructured":"Dai, X., Yu, K., Chang, Y., & Hou, Y. (2024). Drug-induced urinary retention: A real-world pharmacovigilance study using FDA and canada vigilance databases. Frontiers In Pharmacology, 15, 1466875.","journal-title":"Frontiers In Pharmacology"},{"key":"10174_CR13","doi-asserted-by":"publisher","first-page":"e0176222","DOI":"10.1371\/journal.pone.0176222","volume":"12","author":"YG Kim","year":"2017","unstructured":"Kim, Y. G., Shin, D., Park, M. Y., et al. (2017). ECG-ViEW II, a freely accessible electrocardiogram database. PLOS One, 12, e0176222.","journal-title":"PLOS One"},{"key":"10174_CR14","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.jacc.2016.07.761","volume":"68","author":"T Lorberbaum","year":"2016","unstructured":"Lorberbaum, T., Sampson, K. J., Chang, J. B., et al. (2016). Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation. Journal Of The American College Of Cardiology, 68, 1756\u20131764.","journal-title":"Journal Of The American College Of Cardiology"},{"key":"10174_CR15","first-page":"50","volume":"78","author":"L Brunetti","year":"2019","unstructured":"Brunetti, L., Lee, S-M., Nahass, R. G., et al. (2019). The risk of cardiac events in patients who received concomitant levofloxacin and amiodarone. International Journal Of Infectious Diseases : Ijid : Official Publication Of The International Society For Infectious Diseases, 78, 50\u201356.","journal-title":"International Journal Of Infectious Diseases : Ijid : Official Publication Of The International Society For Infectious Diseases"},{"key":"10174_CR16","first-page":"37","volume":"2014","author":"M Jiang","year":"2014","unstructured":"Jiang, M., Wu, Y., Shah, A., Priyanka, P., Denny, J. C., & Xu, H. (2014). Extracting and standardizing medication information in clinical text - the MedEx-UIMA system. AMIA Joint Summits on Translational Science proceedings, 2014, 37\u201342.","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"key":"10174_CR17","doi-asserted-by":"crossref","unstructured":"Zhou, J., Lai, W., Wei, Z. (2024). Exploring the link between exogenous thyroid hormones and dementia symptoms: A real-world disproportionality analysis of FDA adverse event reporting system. Annals Of Pharmacotherapy, 10600280241252211.","DOI":"10.1177\/10600280241252211"},{"key":"10174_CR18","doi-asserted-by":"crossref","unstructured":"Zhao, H., Ni, P., Zhao, Q. (2023). Identifying the serious clinical outcomes of adverse reactions to drugs by a multi-task deep learning framework. Communications Biology, 6. https:\/\/www.nature.com\/articles\/s42003-023-05243-w. Accessed 8 July 2026.","DOI":"10.1038\/s42003-023-05243-w"},{"key":"10174_CR19","doi-asserted-by":"crossref","unstructured":"Ca, G., D, K., & Dr, M. (2023). F M, A D. Concomitant use of statins and sodium-glucose co-transporter 2 inhibitors and the risk of myotoxicity reporting: A disproportionality analysis. British journal of clinical pharmacology, 89. https:\/\/pubmed.ncbi.nlm.nih.gov\/36912450\/. Accessed 2 Dec 2024.","DOI":"10.1111\/bcp.15711"},{"key":"10174_CR20","doi-asserted-by":"publisher","first-page":"1378010","DOI":"10.3389\/fphar.2024.1378010","volume":"15","author":"P Long","year":"2024","unstructured":"Long, P., Li, S., Pan, L., Wang, Y., Chen, W., & Wang, X. (2024). Cardiovascular adverse events associated with antibody-drug conjugates (ADCs): A pharmacovigilance study based on the FAERS database. Frontiers In Pharmacology, 15, 1378010.","journal-title":"Frontiers In Pharmacology"},{"key":"10174_CR21","first-page":"e60492","volume":"16","author":"A Agnihotri","year":"2024","unstructured":"Agnihotri, A., Ramasubbu, S. K., Bandyopadhyay, A., Bidarolli, M., Nath, U. K., & Das, B. (2024). Prevalence, attributes, and risk factors of QT-interval-prolonging drugs and potential drug-drug interactions in cancer patients: A prospective study in a tertiary care hospital. Cureus, 16, e60492.","journal-title":"Cureus"},{"key":"10174_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12873-024-01158-9","volume":"24","author":"AM Alshehri","year":"2024","unstructured":"Alshehri, A. M., Crowley, K. E., Lupi, K. E., Kim, C. S., DeGrado, J. R., & Marino, K. (2024). Evaluation of droperidol use in the emergency department: A retrospective analysis of QTc prolongation and adverse events. Bmc Emergency Medicine, 24, 232.","journal-title":"Bmc Emergency Medicine"},{"key":"10174_CR23","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s12012-022-09764-4","volume":"22","author":"K Ryan","year":"2022","unstructured":"Ryan, K., Benz, P., Zosel, A., Farkas, A., & Theobald, J. (2022). QTc prolongation in poison center exposures to CredibleMeds list of substances with known risk of torsades de pointes. Cardiovascular Toxicology, 22, 866\u2013877.","journal-title":"Cardiovascular Toxicology"},{"key":"10174_CR24","doi-asserted-by":"publisher","first-page":"1320458","DOI":"10.3389\/fphar.2023.1320458","volume":"14","author":"F Zou","year":"2023","unstructured":"Zou, F., Zhu, C., Lou, S., et al. (2023). A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database. Frontiers In Pharmacology, 14, 1320458.","journal-title":"Frontiers In Pharmacology"},{"key":"10174_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11095-020-02801-3","volume":"37","author":"Y Noguchi","year":"2020","unstructured":"Noguchi, Y., Tachi, T., & Teramachi, H. (2020). Comparison of signal detection algorithms based on frequency statistical model for drug-drug interaction using spontaneous reporting systems. Pharmaceutical Research, 37, 86.","journal-title":"Pharmaceutical Research"},{"key":"10174_CR26","doi-asserted-by":"publisher","first-page":"e1236","DOI":"10.1002\/prp2.1236","volume":"12","author":"L Shu","year":"2024","unstructured":"Shu, L., Huo, B-N., Yin, N-G., et al. (2024). Clinical drug interactions between linezolid and other antibiotics: For adverse drug event monitoring. Pharmacology Research & Perspectives, 12, e1236.","journal-title":"Pharmacology Research & Perspectives"},{"key":"10174_CR27","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1038\/s41598-023-27687-0","volume":"13","author":"H Li","year":"2023","unstructured":"Li, H., Zhang, M., Jiao, X., et al. (2023). Using disproportionality analysis to explore the association between periostitis and triazole antifungals in the FDA adverse event reporting system database. Scientific Reports, 13, 4475.","journal-title":"Scientific Reports"},{"key":"10174_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13054-022-04016-x","volume":"26","author":"TDY Reijnders","year":"2022","unstructured":"Reijnders, T. D. Y., Peters-Sengers, H., van Vught, L. A., et al. (2022). Effect of erythromycin on mortality and the host response in critically ill patients with sepsis: A target trial emulation. Critical Care, 26, 151.","journal-title":"Critical Care"},{"key":"10174_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5582\/irdr.2020.01016","volume":"9","author":"I Cenzer","year":"2020","unstructured":"Cenzer, I., Boscardin, W. J., & Berger, K. (2020). Performance of matching methods in studies of rare diseases: A simulation study. Intractable & Rare Diseases, 9, 79\u201388.","journal-title":"Intractable Rare Dis Res"},{"key":"10174_CR30","doi-asserted-by":"publisher","first-page":"e2441615","DOI":"10.1001\/jamanetworkopen.2024.41615","volume":"7","author":"Y Gao","year":"2024","unstructured":"Gao, Y., Wang, Y., Chen, L., Xie, J., & Prieto-Alhambra, D. (2024). Hospitalization for COVID-19, other respiratory infections, and postacute patient-reported symptoms. JAMA Network Open, 7, e2441615.","journal-title":"JAMA Network Open"},{"key":"10174_CR31","doi-asserted-by":"publisher","first-page":"1292163","DOI":"10.3389\/fphar.2024.1292163","volume":"15","author":"B-N Huo","year":"2024","unstructured":"Huo, B-N., Shu, L., Xiao, J-W., et al. (2024). Clinical drug interactions between voriconazole and 38 other drugs: A retrospective analysis of adverse events. Frontiers In Pharmacology, 15, 1292163.","journal-title":"Frontiers In Pharmacology"},{"key":"10174_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1001\/jamacardio.2022.4466","volume":"8","author":"NA Marston","year":"2023","unstructured":"Marston, N. A., Pirruccello, J. P., Melloni, G. E. M., et al. (2023). Predictive utility of a coronary artery disease polygenic risk score in primary prevention. JAMA Cardiology, 8, 130\u2013137.","journal-title":"JAMA Cardiol"},{"key":"10174_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10557-023-07425-4","volume":"38","author":"W Fan","year":"2024","unstructured":"Fan, W., Liu, H., Shen, Y., & Hong, K. (2024). The association of proton pump inhibitors and QT interval prolongation in critically ill patients. Cardiovascular Drugs And Therapy, 38, 517\u2013525.","journal-title":"Cardiovascular Drugs And Therapy"},{"key":"10174_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40801-021-00234-x","volume":"8","author":"M Rossi","year":"2021","unstructured":"Rossi, M., Marzi, F., Natale, M., et al. (2021). Drug-associated QTc prolongation in geriatric hospitalized patients: A cross-sectional study in internal medicine. Drugs Real World Outcomes, 8, 325\u2013335.","journal-title":"Drugs Real World Outcomes"},{"key":"10174_CR35","doi-asserted-by":"publisher","first-page":"e010042","DOI":"10.1161\/CIRCEP.121.010042","volume":"14","author":"PE Lazzerini","year":"2021","unstructured":"Lazzerini, P. E., Cartocci, A., Qu, Y. S., et al. (2021). Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US veterans. Circ Arrhythm Electrophysiol, 14, e010042.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10174_CR36","unstructured":"Mojica, R. P., Vel\u00e1squez, H. G., Meza, A., Montiel, L. S., & Galvis, N. P. (2025). Increased sodium levels associated with ceftriaxone administration: Case report. IJPS Journal. https:\/\/www.ijpsjournal.com\/article\/Increased+Sodium+Levels+Associated+with+Ceftriaxone+Administration+Case+Report. Accessed 16 May 2025."},{"key":"10174_CR37","first-page":"702","volume":"26","author":"ML Christensen","year":"2021","unstructured":"Christensen, M. L., Zareie, P., Kadiyala, B., et al. (2021). Concomitant ceftriaxone and intravenous calcium therapy in infants. JJournal of Pediatric Pharmacology and Therapeutics, 26, 702\u2013707.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10174_CR38","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.jacc.2016.11.090","volume":"69","author":"PE Lazzerini","year":"2017","unstructured":"Lazzerini, P. E., Bertolozzi, I., Rossi, M., Capecchi, P. L., & Laghi-Pasini, F. (2017). Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk. Journal Of The American College Of Cardiology, 69, 1876\u20131877.","journal-title":"Journal Of The American College Of Cardiology"},{"key":"10174_CR39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s12012-020-09577-3","volume":"20","author":"J Wolfes","year":"2020","unstructured":"Wolfes, J., Ellermann, C., Burde, S., et al. (2020). Concomitant Treatment with Proton Pump Inhibitors and Cephalosporins Does Not Enhance QT-Associated Proarrhythmia in Isolated Rabbit Hearts. Cardiovascular Toxicology, 20, 531\u2013538.","journal-title":"Cardiovascular Toxicology"},{"key":"10174_CR40","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1056\/NEJMra032426","volume":"350","author":"DM Roden","year":"2004","unstructured":"Roden, D. M. (2004). Drug-induced prolongation of the QT interval. New England Journal Of Medicine, 350, 1013\u20131022.","journal-title":"New England Journal Of Medicine"},{"key":"10174_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1476-5381.2011.01367.x","volume":"164","author":"A Varr\u00f3","year":"2011","unstructured":"Varr\u00f3, A., & Baczk\u00f3, I. (2011). Cardiac ventricular repolarization reserve: A principle for understanding drug-related proarrhythmic risk. British Journal Of Pharmacology, 164, 14\u201336.","journal-title":"British Journal Of Pharmacology"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10174-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:46:46Z","timestamp":1792144006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10174-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,6]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10174"],"URL":"https:\/\/doi.org\/10.1007\/s12012-026-10174-z","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,6]]},"assertion":[{"value":"7 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All databases employed rigorous anonymization and de-identification protocols for patient records to ensure compliance with privacy protection standards. Accordingly, this study was exempt from institutional ethics committee review and informed consent requirements under the applicable regulations. This observational real-world pharmacovigilance cohort study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines and the Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV).","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"103"}}